The susceptibility of Philadelphia chromosome positive cells to FAS- mediated apoptosis is not linked to the tyrosine kinase activity of BCR-ABL

British Journal of Haematology

Volumn 103, Issue 3, 1998, Pages 716-720

  Gora Tybor, Joanna ^a,b   Deininger, Michael W M ^a   Goldman, John M ^a   Melo, Junia V ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Apoptosis; BCR ABL; CML; FAS; Tyrosine kinase

Indexed keywords

BCR ABL PROTEIN; CD34 ANTIGEN; CYTOKINE; FAS ANTIGEN; IMATINIB; IMMUNOGLOBULIN M; MESSENGER RNA; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

ANTIGENS, CD34; ANTIGENS, CD95; APOPTOSIS; ENZYME INHIBITORS; FUSION PROTEINS, BCR-ABL; HUMANS; LEUKEMIA, MYELOID, CHRONIC; PHILADELPHIA CHROMOSOME; PIPERAZINES; PROTEIN-TYROSINE KINASES; PYRIMIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0031729509     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.01039.x     Document Type: Article

References (17)

1. Albrecht, T., Schwab, R., Henkes, M., Peschel, C., Huber, C. & Aulitzky, W.E. (1996) Primary proliferating immature myeloid cells from CML patients are not resistant to induction of apoptosis by DNA damage and growth factor withdrawal. British Journal of Haematology, 95, 501-507.
2. Amos, T.A., Lewis, J.L., Grand, F.H., Gooding, R.P., Goldman, J.M. & Gordon, M.Y. (1995) Apoptosis in chronic myeloid leukaemia: normal responses by progenitor cells to growth factor deprivation. X-irradiation and glucocorticoids. British Journal of Haematology. 91, 387-393.
3. Cortez., D., Kadlec, L. & Pendergast, A.M. (1945) Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis. Molecular Cell Biology, 15, 5531-5541.
4. Cross, N.C., Melo, J.V. Feng, L. & Goldman, J.M. (1994) An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in hematological disorders. Leukemia, 8, 186-189.
5. Deininger, M.W.N., Goldman, J.M., Lydon, N.B. & Melo. J.V. (1997) The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL positive cells. Blood, 90, 3691-3698.
6. Druker, B.J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G.M., Fanning. S., Zimmermann, J. & Lydon, N.B. (1996) Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nature Medicine, 2, 561-566.
7. Friesen, C., Herr, I., Krammer, P.H. & Debatin, K.M. (1996) Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukaemia cells. Nature Medicine, 2, 574-577.
8. Hochhaus, A., Lin, F., Reiter, A., Skladny, H., Mason. P.J., van Rhee, F., Shepherd, P.C., Allan, N.C., Hehlmann, R., Goldman, J.M. & Cross, N.C. (1996) Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction. Blood, 87, 1549-1555.
9. Laneuville, P. (1995) Abl tyrosine protein kinase. Seminars in Immunology, 7, 255-266.
10. McGahon, A.J., Nishioka, W.K., Martin, S.J., Mahbonbi, A., Cotter, T.G. & Green, D.R. (1995) Regulation of the Fas apoptotic cell death pathway by Abl. Journal of Biological Chemistry, 270, 22625-22631.
11. Melo, J.V. (1996) The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood, 88, 2375-2384.
12. Nagafuji, K., Tsunefumi, S., Harada, M., Mizuno, S., Takenaka, M., Miyamoto, T., Okamura, T., Gondo, H. & Niho, Y. (1995) Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood, 86, 883-889.
13. Sanchez Garcia, I. & Martin Zanca, D. (1997) Regulation of Bcl-2 gene expression by BCR-ABL is mediated by Ras. Journal of Molecular Biology, 267, 225-228.
14. Selleri, C., Sato, T., Del Vecchio, L., Luciano, L., Barrett, A.J., Rotoli, B., Young, N.S. & Maciejewski, J.P. (1997) Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-alpha in chronic myelogenous leukemia. Blood, 89, 957-964.
15. Takahashi, T., Tanaka, M., Inazawa, J., Abe, T., Suda, T. & Nagata, S. (1994) Human Fas ligand: gene structure, chromosomal location and species specificity, International Immunology, 6, 1567-1574.
16. Telford, W.G., King, L.E. & Fraker. P.J. (1994) Rapid quantitation of apoptosis in pure and heterogeneous cell populations using flow cytometry. Journal of Immunological Methods, 172, 1-16.
17. Zha, J., Harada, H., Yang, E., Jockel, J. & Korsmeyer, S.J. (1996) Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell, 87, 619-628.